BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21565914)

  • 1. Effectiveness and safety of leflunomide for pulmonary and extrapulmonary sarcoidosis.
    Sahoo DH; Bandyopadhyay D; Xu M; Pearson K; Parambil JG; Lazar CA; Chapman JT; Culver DA
    Eur Respir J; 2011 Nov; 38(5):1145-50. PubMed ID: 21565914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long term follow-up of infliximab efficacy in pulmonary and extra-pulmonary sarcoidosis refractory to conventional therapy.
    Russell E; Luk F; Manocha S; Ho T; O'Connor C; Hussain H
    Semin Arthritis Rheum; 2013 Aug; 43(1):119-24. PubMed ID: 23332903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leflunomide for chronic sarcoidosis.
    Baughman RP; Lower EE
    Sarcoidosis Vasc Diffuse Lung Dis; 2004 Mar; 21(1):43-8. PubMed ID: 15127974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Striking leflunomide efficacy against refractory cutaneous sarcoidosis.
    Bohelay G; Bouaziz JD; Nunes H; Rybojad M; Bagot M; Petit A; Laroche L
    J Am Acad Dermatol; 2014 May; 70(5):e111-3. PubMed ID: 24742855
    [No Abstract]   [Full Text] [Related]  

  • 5. Leflunomide as adjuvant treatment of dermatomyositis.
    Boswell JS; Costner MI
    J Am Acad Dermatol; 2008 Mar; 58(3):403-6. PubMed ID: 18194823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomised controlled trial of leflunomide in the treatment of immunoglobulin A nephropathy.
    Lou T; Wang C; Chen Z; Shi C; Tang H; Liu X; Yin P; Yu X
    Nephrology (Carlton); 2006 Apr; 11(2):113-6. PubMed ID: 16669971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leflunomide, a novel immunomodulator for the treatment of active rheumatoid arthritis.
    Goldenberg MM
    Clin Ther; 1999 Nov; 21(11):1837-52; discussion 1821. PubMed ID: 10890256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin is a safe and effective treatment for chronic pulmonary and extrapulmonary sarcoidosis.
    Pignone AM; Rosso AD; Fiori G; Matucci-Cerinic M; Becucci A; Tempestini A; Livi R; Generini S; Gramigna L; Benvenuti C; Carossino AM; Conforti ML; Perfetto F
    J Pineal Res; 2006 Sep; 41(2):95-100. PubMed ID: 16879313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term treatment with infliximab in patients with sarcoidosis.
    Hostettler KE; Studler U; Tamm M; Brutsche MH
    Respiration; 2012; 83(3):218-24. PubMed ID: 21811048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thalidomide for improving cutaneous and pulmonary sarcoidosis in patients resistant or with contraindications to corticosteroids.
    Fazzi P; Manni E; Cristofani R; Cei G; Piazza S; Calabrese R; Antonelli A; Siciliano G; Barachini P; Carpi A
    Biomed Pharmacother; 2012 Jun; 66(4):300-7. PubMed ID: 22494798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Established and experimental medical therapy of pulmonary sarcoidosis.
    Baughman RP; Nunes H; Sweiss NJ; Lower EE
    Eur Respir J; 2013 Jun; 41(6):1424-38. PubMed ID: 23397302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leflunomide-induced toxic epidermal necrolysis.
    Teraki Y; Hitomi K; Sato Y; Hamamatsu Y; Izaki S
    Int J Dermatol; 2006 Nov; 45(11):1370-1. PubMed ID: 17076730
    [No Abstract]   [Full Text] [Related]  

  • 13. [Specific features of diagnosis and treatment of patients with pulmonary sarcoidosis and tuberculosis].
    Kostina ZI; Brazhenko NA; Gerasimova EV; Kol'nikova OV
    Probl Tuberk; 1998; (2):10-3. PubMed ID: 9613175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term effect of leflunomide in patients with Takayasu arteritis: an observational study.
    de Souza AW; da Silva MD; Machado LS; Oliveira AC; Pinheiro FA; Sato EI
    Scand J Rheumatol; 2012 May; 41(3):227-30. PubMed ID: 22400913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of short-course, low-dose corticosteroid therapy for acute pulmonary sarcoidosis exacerbations.
    McKinzie BP; Bullington WM; Mazur JE; Judson MA
    Am J Med Sci; 2010 Jan; 339(1):1-4. PubMed ID: 19996733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of leflunomide in patients with juvenile idiopathic arthritis in clinical practice.
    Foeldvari I; Wierk A
    J Rheumatol; 2010 Aug; 37(8):1763-7. PubMed ID: 20472925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance of remission with leflunomide in Wegener's granulomatosis.
    Metzler C; Fink C; Lamprecht P; Gross WL; Reinhold-Keller E
    Rheumatology (Oxford); 2004 Mar; 43(3):315-20. PubMed ID: 14963200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leflunomide induced acute interstitial pneumonia.
    Takeishi M; Akiyama Y; Akiba H; Adachi D; Hirano M; Mimura T
    J Rheumatol; 2005 Jun; 32(6):1160-3. PubMed ID: 15940779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leflunomide treatment of Crohn's disease patients intolerant to standard immunomodulator therapy.
    Prajapati DN; Knox JF; Emmons J; Saeian K; Csuka ME; Binion DG
    J Clin Gastroenterol; 2003 Aug; 37(2):125-8. PubMed ID: 12869881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy and safety of leflunomide in patients with active rheumatoid arthritis.
    Wiacek R; Kolossa K; Jankowski T; Jeka S; Karmowski A; Karmowski M; Gworys B
    Adv Clin Exp Med; 2012; 21(3):337-42. PubMed ID: 23214197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.